Cargando…

Appropriateness of Dyslipidemia Management Strategies in Post-Acute Coronary Syndrome: A 2023 Update

It has been consistently demonstrated that circulating lipids and particularly low-density lipoprotein cholesterol (LDL-C) play a significant role in the development of coronary artery disease (CAD). Several trials have been focused on the reduction of LDL-C values in order to interfere with atherot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lucà, Fabiana, Oliva, Fabrizio, Rao, Carmelo Massimiliano, Abrignani, Maurizio Giuseppe, Amico, Antonio Francesco, Di Fusco, Stefania Angela, Caretta, Giorgio, Di Matteo, Irene, Di Nora, Concetta, Pilleri, Anna, Ceravolo, Roberto, Rossini, Roberta, Riccio, Carmine, Grimaldi, Massimo, Colivicchi, Furio, Gulizia, Michele Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456563/ https://www.ncbi.nlm.nih.gov/pubmed/37623860 http://dx.doi.org/10.3390/metabo13080916

Ejemplares similares

Management of oral anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation
por: Lucà, Fabiana, et al.
Publicado: (2023)

A Tailored Antithrombotic Approach for Patients with Atrial Fibrillation Presenting with Acute Coronary Syndrome and/or Undergoing PCI: A Case Series
por: Giubilato, Simona, et al.
Publicado: (2022)

Management of Residual Risk in Chronic Coronary Syndromes. Clinical Pathways for a Quality-Based Secondary Prevention
por: Giubilato, Simona, et al.
Publicado: (2023)

Management of Acute Coronary Syndrome in Cancer Patients: It’s High Time We Dealt with It
por: Lucà, Fabiana, et al.
Publicado: (2022)

The role of the pregnancy heart team in clinical practice
por: Lucà, Fabiana, et al.
Publicado: (2023)

Reply to Kielb et al. Untapped Potential for Female Patients? Comment on “Lucà et al. Update on Management of Cardiovascular Diseases in Women. J. Clin. Med. 2022, 11, 1176”
por: Lucà, Fabiana, et al.
Publicado: (2022)

Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios
por: Lucà, Fabiana, et al.
Publicado: (2023)

ANMCO Position Paper: direct oral anticoagulants for stroke prevention in atrial fibrillation: clinical scenarios and future perspectives
por: Nardi, Federico, et al.
Publicado: (2017)

ANMCO-SIMEU consensus document: appropriate management of atrial fibrillation in the emergency department
por: Caldarola, Pasquale, et al.
Publicado: (2023)

Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management
por: Lucà, Fabiana, et al.
Publicado: (2023)

ANMCO Position Paper: diagnostic–therapeutic pathway in patients with hypercholesterolaemia and statin intolerance
por: Gulizia, Michele Massimo, et al.
Publicado: (2017)

ANMCO Scientific Statement: clinical management of hypercholesterolaemia in patients with acute coronary syndromes
por: Colivicchi, Furio, et al.
Publicado: (2017)

Spotlight on Italian Association of Hospital Cardiologists (ANMCO) activity in the 2–year period 2021–2023
por: Di Fusco, Stefania Angela, et al.
Publicado: (2023)

ANMCO position paper: 2022 focused update of appropriate use criteria for multimodality imaging: aortic valve disease
por: Nardi, Federico, et al.
Publicado: (2022)

Clinical Utility of Three-Dimensional Echocardiography in the Evaluation of Mitral Valve Disease: Tips and Tricks
por: Pino, Paolo G., et al.
Publicado: (2023)

Update on Management of Cardiovascular Diseases in Women
por: Lucà, Fabiana, et al.
Publicado: (2022)

COVID-19, Vaccines, and Thrombotic Events: A Narrative Review
por: Abrignani, Maurizio G., et al.
Publicado: (2022)

Direct Oral Anticoagulants in Patients with Obesity and Atrial Fibrillation: Position Paper of Italian National Association of Hospital Cardiologists (ANMCO)
por: Mocini, David, et al.
Publicado: (2021)

ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathy
por: Riccio, Carmine, et al.
Publicado: (2017)

Screening and management of dyslipidemia in oncologic patients undergoing cardiotoxic therapies: results from an Italian survey
por: Camilli, Massimiliano, et al.
Publicado: (2023)

Characteristics, treatment and quality of life of stable coronary artery disease patients with or without angina: Insights from the START study
por: De Luca, Leonardo, et al.
Publicado: (2018)

Anticoagulation in Atrial Fibrillation Cardioversion: What Is Crucial to Take into Account
por: Lucà, Fabiana, et al.
Publicado: (2021)

ANMCO position paper ‘Appropriateness of prescribing direct oral anticoagulants in stroke and systemic thromboembolism prevention in adult patients with non-valvular atrial fibrillation’
por: Mocini, David, et al.
Publicado: (2022)

Impact of Working from Home on Cardiovascular Health: An Emerging Issue with the COVID-19 Pandemic
por: Di Fusco, Stefania Angela, et al.
Publicado: (2021)

Italian Association of Hospital Cardiologists practical guidance for sodium–glucose cotransporter 2 inhibitors use in patients with heart failure
por: Di Fusco, Stefania Angela, et al.
Publicado: (2023)

Electrocardiographic characteristics, anthropometric features, and cardiovascular risk factors in a large cohort of adolescents
por: Santini, Massimo, et al.
Publicado: (2018)

ANMCO POSITION PAPER: Prognostic and therapeutic relevance of non-obstructive coronary atherosclerosis
por: Casolo, Giancarlo, et al.
Publicado: (2021)

ANMCO POSITION PAPER: Use of sacubitril/valsartan in hospitalized patients with acute heart failure
por: Di Tano, Giuseppe, et al.
Publicado: (2021)

The Impact of the Coronavirus Disease-2019 Pandemic and Italian Lockdown Measures on Clinical Presentation and Management of Acute Heart Failure
por: Colivicchi, Furio, et al.
Publicado: (2020)

Incidence, Characteristics, and Management of Patients with Recurrent Myocardial Infarctions: Insights from the EYESHOT POST-MI
por: De Luca, Leonardo, et al.
Publicado: (2022)

Superiority of Direct Oral Anticoagulants over Vitamin K Antagonists in Oncological Patients with Atrial Fibrillation: Analysis of Efficacy and Safety Outcomes
por: Parrini, Iris, et al.
Publicado: (2022)

ANMCO position paper: guide to the appropriate use of the wearable cardioverter defibrillator in clinical practice for patients at high transient risk of sudden cardiac death
por: Casolo, Giancarlo, et al.
Publicado: (2023)

Type of hospitalisations and in-hospital outcomes in the Italian coronary care unit network at the time of COVID-19 pandemic: the BLITZ-COVID19 Registry
por: Gulizia, Michele Massimo, et al.
Publicado: (2022)

BLITZ‐HF: a nationwide initiative to evaluate and improve adherence to acute and chronic heart failure guidelines
por: Gulizia, Michele Massimo, et al.
Publicado: (2022)

ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO)
por: Bisceglia, Irma, et al.
Publicado: (2021)

Clinical Impact and Prognostic Role of Triglyceride to High-Density Lipoprotein Cholesterol Ratio in Patients With Chronic Coronary Syndromes at Very High Risk: Insights From the START Study
por: De Luca, Leonardo, et al.
Publicado: (2022)

ANMCO position paper on vericiguat use in heart failure: from evidence to place in therapy
por: Di Fusco, Stefania Angela, et al.
Publicado: (2023)

ANMCO statement on the use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a practical guide for a streamlined implementation
por: Di Fusco, Stefania Angela, et al.
Publicado: (2022)

ANMCO position paper on the management of hypercholesterolaemia in patients with acute coronary syndrome
por: De Luca, Leonardo, et al.
Publicado: (2023)

Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story
por: Bisceglia, Irma, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_brq605ej3ddf2rn8smapbchkha